Patent · US Active

Pyruvate kinase activators for use in therapy

US10632114B2 · kind B2 · utility

6Cited by
68References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 27, 2018
Grant dateApr 28, 2020
Priority date—
Expiry dateApr 27, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D307/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are methods for using compounds that activate pyruvate kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.